Prices are updated after-hours

N::A 1

VISION SENSING ACQUISITION CORP.

VSAC | $11.13 0.0% 24K

(0.0% 1d) (0.0% 1m) (5.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 20,265,114

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Semper Paratus Acquisition Corp

LGST | $4.51 -11.31% 13K

n/a

(0.0% 1d) (0.0% 1m) (-57.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (213.02% volume)
Earnings Calendar:
Market Cap: $ 64,717,476

Sec Filling | Patents | 2021 employees

add to watch list Paper trade email alert is off

Nubia Brand International Corp.

NUBI | $4.53 -11.7% 78K

n/a

(0.0% 1d) (0.0% 1m) (-56.6% 1y) (0.0% 2d) (-11.1% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 32,301,695

Sec Filling | Patents | 2021 employees

nubia brand international corp. is a special purpose acquisition company (spac) headquartered in dallas, tx

spac

add to watch list Paper trade email alert is off

ISRAEL DISCOUNT BANK LTD

ISDAF | $5.13 29.59% 100

n/a

(0.0% 1m) (3.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.91% volume)
Earnings Calendar:
Market Cap: $ 6,345,867,933
http://www.discountbank.co.il
Sec Filling | Patents | n/a employees

(IL) Israel Discount Bank Ltd. is a bank which engages in providing comprehensive banking services to its clients in areas of finance, through a network of branches in Israel, direct banking, online banking and Internet. It operates through the following segments: Household, Private Banking, Minute Businesses, Small Businesses, Medium Businesses, Large Businesses, Institutional Bodies, Financial Management, and Other. The company was founded by Leon Recanati in 1935 and is headquartered in Tel Aviv, Israel.

israel urea

add to watch list Paper trade email alert is off

Boliden AB

BOLIF | $34.65 -8.1% 140

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-80.71% volume)
Earnings Calendar:
Market Cap: $ 9,477,162,006
https://www.boliden.com/
Sec Filling | Patents | n/a employees

(SE)

add to watch list Paper trade email alert is off

Mobilicom Ltd

MILOF | $0.0008 0% 1.1K

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (10.0% volume)
Earnings Calendar:
Market Cap: $ 5,906,041
https://www.crosswordcybersecurity.com
Sec Filling | Patents | 2 employees

crossword cybersecurity is a technology commercialisation company focusing exclusively on the cyber security sector. we work with research intensive european university partners to identify promising cyber security intellectual property ("ip") from research that our industry partners tell us meet emerging real-world challenges. our specialist cyber security software engineering team work with our university partners to develop the research concept into a fully fledged commercial product that we bring to market. our first product, rizikon (www.rizikon.io) is a cyber risk analysis and investment prioritisation tool that can help you understand where your biggest vulnerabilities are and how to invest in protecting against them. crossword cybersecurity plc was founded in 2014.

add to watch list Paper trade email alert is off

Silo Pharma, Inc.

SILOD | $6.76

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-21.7% volume)
Earnings Calendar:
Market Cap: $ 672,148,862

Sec Filling | Patents | 1 employees

add to watch list Paper trade email alert is off

Ampio Pharmaceuticals, Inc.

AMPED | $0.51

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (99.39% volume)
Earnings Calendar:
Market Cap: $ 115,406,302
https://ampiopharma.com
Sec Filling | Patents | 18 employees

(US) Ampio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company primarily engaged in the development of AmpionTM, its lead anti-inflammatory drug, which is currently undergoing clinical trials focused on the treatment of patients afflicted with COVID-19 induced acute respiratory distress syndrome (ARDS) as well as patients suffering from severe (KL-4) osteoarthritis of the knee (OAK). Both conditions impact a significant percentage of the population and due to the lack of any FDA approved drugs for treatment, there exists a significant unmet medical need. Ampion is backed by an extensive global patent portfolio with intellectual property protection extending through 2035. In addition, Ampion will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (BPCIA).

treatment msa respiratory covid

add to watch list Paper trade email alert is off

AVITA Medical, Inc.

AVHHL | $3.203 -18.83% 650

n/a

(0.0% 1d) (0.0% 1m) (3.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-2.4% volume)
Earnings Calendar:
Market Cap: $ 437,013,255
http://www.avitamedical.com/
Sec Filling | Patents | 2021 employees

(US) avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.

add to watch list Paper trade email alert is off

INVACARE CORP

IVCRQ | $0.0135 25.93% 110K

n/a

(0.0% 1d) (-6.9% 1m) (-10.6% 1y) (-6.9% 2d) (-6.9% 3d) (0.0% 7d) (-71.86% volume)
Earnings Calendar: 2023-02-15
Market Cap: $ 512,763
https://www.invacare.com
Sec Filling | Patents | 3000 employees

(US) Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.

add to watch list Paper trade email alert is off

Boliden AB

BLIDF | $25.07 0% 7.4K

n/a

(0.0% 1d) (0.0% 1m) (-7.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (5850.4% volume)
Earnings Calendar:
Market Cap: $ 6,856,925,007
https://www.boliden.com/
Sec Filling | Patents | n/a employees

(SE)

add to watch list Paper trade email alert is off

Global Crossing Airlines Group Inc.

JETBF | $0.57 0% 400

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 7,391,879
https://www.jetlines.ca/
Sec Filling | Patents | n/a employees

(CA)

add to watch list Paper trade email alert is off

INDIVIOR PLC

INVVY | $21.8455 19.02% 8.1K

n/a

(0.0% 1d) (0.0% 1m) (-9.4% 1y) (-1.8% 2d) (-1.2% 3d) (0.0% 7d) (459.6% volume)
Earnings Calendar:
Market Cap: $ 3,012,026,498
http://indivior.com/
Sec Filling | Patents | n/a employees

(United Kingdom)

add to watch list Paper trade email alert is off

TH International Ltd

THCH | $1.04 0.0% 170K

n/a

(0.0% 1d) (-14.0% 1m) (-79.2% 1y) (0.0% 2d) (2.0% 3d) (-3.7% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 154,289,296

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

ZEVRA THERAPEUTICS, INC.

ZVRA | $4.66 -2.31% -2.36% 210K

n/a

(0.0% 1d) (-20.0% 1m) (-22.3% 1y) (0.0% 2d) (-0.3% 3d) (-3.4% 7d) (-21.8% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 202,366,027
https://www.kempharm.com
Sec Filling | Patents | 24 employees

(US) KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT™ technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.

treatment profitable

add to watch list Paper trade email alert is off

Veralto Corp

VLTO | $90.55 -0.37% 0.0% 2.3M

n/a

(0.0% 1d) (4.4% 1m) (6.8% 1y) (0.0% 2d) (1.1% 3d) (4.0% 7d) (-2.8% volume)
Earnings Calendar:
Market Cap: $ 22,355,766,443

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

United Maritime Corp

USEA | $2.55 2.41% 2.35% 41K

n/a

(0.0% 1d) (-15.6% 1m) (-7.1% 1y) (0.0% 2d) (0.0% 3d) (-0.6% 7d) (-24.41% volume)
Earnings Calendar:
Market Cap: $ 22,171,307

Sec Filling | Patents | 2022 employees

add to watch list Paper trade email alert is off

SELINA HOSPITALITY PLC

SLNA | $0.065 2.36% 2.31% 8.1M

n/a

(0.0% 1d) (-69.3% 1m) (-96.0% 1y) (0.0% 2d) (-9.8% 3d) (-20.6% 7d) (363.02% volume)
Earnings Calendar: 2023-12-13
Market Cap: $ 6,361,276

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

SYLA Technologies Co., Ltd.

SYT | $2.7 2.92% 1.6K

n/a

(0.0% 1d) (-27.8% 1m) (-64.8% 1y) (0.0% 2d) (1.5% 3d) (-1.8% 7d) (288.87% volume)
Earnings Calendar:
Market Cap: $ 70,440,570

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

ParaZero Technologies Ltd.

PRZO | $0.8169 -4.92% -5.18% 1.7M

n/a

(0.0% 1d) (22.7% 1m) (-76.1% 1y) (0.0% 2d) (-27.2% 3d) (10.2% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 8,827,889

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off